Granules' US unit gets two USFDA observations

As per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgment may constitute violations of FD&C Act.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OWmLY8
via IFTTT